Showing 10,121 - 10,140 results of 105,667 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.98s Refine Results
  1. 10121
  2. 10122
  3. 10123

    Data extraction grid. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  4. 10124

    Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  5. 10125

    Inclusion criteria. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  6. 10126
  7. 10127

    PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  8. 10128
  9. 10129
  10. 10130
  11. 10131
  12. 10132
  13. 10133
  14. 10134

    The NK1-receptor antagonist ezlopitant significantly decreases the breakpoint for sucrose but not ethanol operant self-administration in rats. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (5 and 10 mg/kg i.p.) decreases the breakpoint for 5% sucrose using a PR schedule (<b>A</b>), but had no effect on the breakpoint for 10% ethanol (<b>B</b>). …”
  15. 10135

    Decreased <i>Pax2</i> expression in <i>p53<sup>−/−</sup></i> embryonic kidneys. by Zubaida Saifudeen (135684)

    Published 2012
    “…<b>B</b>) In situ hybridization. Decreased expression of <i>Pax2</i> mRNA at E12.5. …”
  16. 10136

    α‑CsCu<sub>5</sub>Se<sub>3</sub>: Discovery of a Low-Cost Bulk Selenide with High Thermoelectric Performance by Ni Ma (676167)

    Published 2020
    “…In compariosn to the isostructural CsAg<sub>5</sub>Te<sub>3</sub>, α-CsCu<sub>5</sub>Se<sub>3</sub> shows a 30% volume decrease that leads to stronger orbital overlapping that markedly decreases the band effective mass (<i>m</i>*). …”
  17. 10137

    α‑CsCu<sub>5</sub>Se<sub>3</sub>: Discovery of a Low-Cost Bulk Selenide with High Thermoelectric Performance by Ni Ma (676167)

    Published 2020
    “…In compariosn to the isostructural CsAg<sub>5</sub>Te<sub>3</sub>, α-CsCu<sub>5</sub>Se<sub>3</sub> shows a 30% volume decrease that leads to stronger orbital overlapping that markedly decreases the band effective mass (<i>m</i>*). …”
  18. 10138

    α‑CsCu<sub>5</sub>Se<sub>3</sub>: Discovery of a Low-Cost Bulk Selenide with High Thermoelectric Performance by Ni Ma (676167)

    Published 2020
    “…In compariosn to the isostructural CsAg<sub>5</sub>Te<sub>3</sub>, α-CsCu<sub>5</sub>Se<sub>3</sub> shows a 30% volume decrease that leads to stronger orbital overlapping that markedly decreases the band effective mass (<i>m</i>*). …”
  19. 10139
  20. 10140

    Sensitivity of N2A stable clones to GCV. by Elizabeth Wei-Chia Luo (11250668)

    Published 2021
    “…<p>(A–L) N2A, N2A-pGFAP-HSVtk, and N2A-pCMV-HSVtk cells were treated separately with 0, 1, 5, or 10 μg/ml of GCV for 5 days, and their live-cell phase images or fluorescent images were captured. …”